Shanghai Healthcare M&A Fund Takes Strategic Stake in MicroPort Scientific Corporation
As a homegrown Chinese innovator that has grown into a global leader in high-end medical devices, MicroPort serves as an anchor company for the industry. Its stable development is critical to both China's and the global high-end medical device supply chain. This investment reflects SHMAF's capital-driven approach to providing crucial support to domestic anchor companies, ensuring their stability and support growth of their core assets. SHMAF will support MicroPort's growth momentum and high-quality sustainable development with its expansive resources.
Introducing a strategic shareholder to drive growth momentum. The transaction brings in a significant strategic shareholder for MicroPort. Leveraging its state-backed resources and industrial expertise, SHMAF will support MicroPort's development needs, core business expansion, and potential strategic mergers and acquisitions to create synergies that bolster the company's ongoing innovation and scale-up its operations.
Optimizing resource allocation to unlock synergistic value. MicroPort has successfully incubated and nurtured multiple listed companies and specialized, highly influential small companies, in the process establishing a unique MicroPort ecosystem. SHMAF will leverage its capital and operational integration expertise to support MicroPort in refining its development strategy, optimizing resource allocation, and unlocking synergistic value—while fully respecting market dynamics and corporate autonomy—to further strengthen its ecosystem and competitive advantages.
Enhancing ecosystem to enhance anchor company value. MicroPort's product portfolio spans across ten major verticals, including cardiovascular intervention, rhythm management, orthopaedics, neurovascular intervention, and surgical robotics, making it a core player in the high-end medical device industrial chain. SHMAF's support will not only drive MicroPort's growth, it will also accelerate its consolidation of upstream and downstream companies in Shanghai, attract highly-skilled talent, and facilitate breakthroughs in critical technologies and core components—ultimately enhancing the global competitiveness of China's high-end medical device industry.
This transaction marks another significant step in SHMAF's commitment to serving biopharmaceutical anchor companies. Upholding its value investment principles, SHMAF will collaborate with MicroPort's shareholders and management team to leverage the strategic support and industrial synergies its state-backed platform offers. Together, they will reinforce MicroPort's position as China's innovation engine in high-end medical devices and contribute to the advancement of the biopharmaceutical industry.
Hashtag: #SIICCapital #MicroPort #SHMAF
The issuer is solely responsible for the content of this announcement.
About MicroPort Scientific Corporation
Founded in 1998 and headquartered in Shanghai's Zhangjiang, MicroPort Scientific Corporation is a leading domestic innovative high-end medical device group. It began by breaking the import monopoly in the cardiovascular stent field, and after 26 years of innovative development, its business has expanded to areas including rhythm management, orthopaedics, cardiovascular intervention, aortic and peripheral vascular intervention, neurovascular intervention, heart valves, surgical robots, and surgical medical devices. By the end of 2024, MicroPort operated in over 20,000 hospitals across 100 countries and regions worldwide, providing more than 600 solutions for patients covering over 200 diseases. MicroPort has incubated 6 A-share and Hong Kong-listed companies, owns 9 specialized and sophisticated SMEs, 4 technology giant enterprises, and 16 national high-tech enterprises, making it an outstanding representative of Shanghai's technological innovation and industrial transformation.
About SIIC Capital
As the active fund management platform under SIIC Group, since its establishment, SIIC Capital has been based in Shanghai, connected with Hong Kong, and oriented towards the world, actively exploring investment opportunities in strategic emerging industries such as biomedicine and green environmental protection. Through a multi-currency, full-stage fund matrix layout, it deeply serves national strategies and the construction of biomedicine highlands.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Android Authority
27 minutes ago
- Android Authority
Cheap gaming handhelds are about to lose their last affordability lifeline in the US
Nick Fernandez / Android Authority TL;DR A new Executive Order ends the $800 duty-free limit for all commercial imports starting August 29. The move closes various shipping loopholes used to avoid earlier China-specific tariffs. Prices for budget gaming handhelds and other devices shipped after the deadline may face steep duties. Remember when we said cheap gaming handhelds were about to get more expensive in the US? Well, it's worse than we thought, and it's happening soon. A new Executive Order from President Trump will end the $800 de minimis exemption for all commercial imports starting August 29, slamming shut the final loopholes some companies were using to keep prices low. As detailed in a new White House Fact Sheet, the wide-reaching order suspends duty-free treatment for low-value shipments regardless of their country of origin. It follows an earlier measure that applied only to goods from China and Hong Kong. In response, some electronics makers began routing packages through Macau to avoid the tariffs, but that strategy won't work once the new rules kick in. Under the updated system, all commercial shipments sent through private couriers will face full duties. Even packages sent through the international postal system will be taxed based on their country of origin. This will either be a percentage-based (ad valorem) tariff or a flat-rate charge ranging from $80 to $200 per item. That could significantly increase the price of devices like the Retroid Pocket Classic or the newly announced AYANEO KONKR Pocket FIT, assuming they continue shipping directly to the US. The move could decimate the budget gaming handheld market in the US, which has thrived on small-batch, low-margin devices sold directly to consumers. The original China-specific tariff imposed at the start of May threatened to push prices up by 30% or more. This new global suspension ensures there are no more workarounds. The order doesn't just target gaming hardware — it's part of a broader crackdown on de minimis abuse, which US officials say has allowed unsafe goods, counterfeits, and even drugs to enter the country with minimal inspection. However, with the new rules taking effect on August 29, any affordable handheld still in transit after that date could get hit with a steep bill. Follow
The Verge
28 minutes ago
- The Verge
All of your international packages are about to get more expensive
President Donald Trump signed an executive order on Wednesday that will suspend the de minimis exemption — which allows packages with goods valued less than $800 to enter the US duty-free — for all countries. Earlier this year, Trump ended the de minimis exemption for goods from China and Hong Kong. The White House says the change goes into effect on August 29th. Per the executive order, for the next six months, goods shipped through the international postal system will either be charged the flat tariff rate based on country of origin (an ad valorem duty) or a specific duty ranging from $80 to $200 per item. After six months, all duties will be calculated as ad valorem duties. The White House's argument for ending the exemption is that packages using it are 'subject to less scrutiny than traditional imports' and could 'pose health, safety, national and economic security risks.' The White House claims that 98 percent of narcotics seizures (by 'number of cases') are from de minimis shipments. It also says that low-value packages from China and Hong Kong accounted for 'the majority of de minimis shipments to the United States.' Posts from this author will be added to your daily email digest and your homepage feed. See All by Jay Peters Posts from this topic will be added to your daily email digest and your homepage feed. See All News Posts from this topic will be added to your daily email digest and your homepage feed. See All Policy
Bloomberg
28 minutes ago
- Bloomberg
Powell Wrong on Holding Rates: Joseph Lavorgna
Joseph Lavorgna, Counselor to Treasury Secretary Scott Bessent, shares his opposing thoughts on Federal Reserve Chair Powell stating interest rates need to stay high to make sure President Trump's tariff policy only increases prices of goods once. Lavorgna also talks about if there's any progress on who will potentially replaced Fed Chair Jerome Powell, and if President Trump will extend the current truce between China & the US. He speaks with Kailey Leinz and Joe Mathieu on the late edition of Bloomberg's "Balance of Power." (Source: Bloomberg)
